BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 35628528)

  • 1. Precision Nephrology in Patients with Diabetes and Chronic Kidney Disease.
    Provenzano M; Maritati F; Abenavoli C; Bini C; Corradetti V; La Manna G; Comai G
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
    Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
    J Nephrol; 2020 Feb; 33(1):9-35. PubMed ID: 31576500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol.
    Gooding KM; Lienczewski C; Papale M; Koivuviita N; Maziarz M; Dutius Andersson AM; Sharma K; Pontrelli P; Garcia Hernandez A; Bailey J; Tobin K; Saunavaara V; Zetterqvist A; Shelley D; Teh I; Ball C; Puppala S; Ibberson M; Karihaloo A; Metsärinne K; Banks RE; Gilmour PS; Mansfield M; Gilchrist M; de Zeeuw D; Heerspink HJL; Nuutila P; Kretzler M; Welberry Smith M; Gesualdo L; Andress D; Grenier N; Shore AC; Gomez MF; Sourbron S;
    BMC Nephrol; 2020 Jun; 21(1):242. PubMed ID: 32600374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
    Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
    Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1127-1150. PubMed ID: 31586514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease.
    Karalliedde J; Winocour P; Chowdhury TA; De P; Frankel AH; Montero RM; Pokrajac A; Banerjee D; Dasgupta I; Fogarty D; Sharif A; Wahba M; Mark PB; Zac-Varghese S; Patel DC; Bain SC
    Diabet Med; 2022 Apr; 39(4):e14769. PubMed ID: 35080257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision Medicine in Diabetic Kidney Disease: A Narrative Review Framed by Lived Experience.
    Downie ML; Desjarlais A; Verdin N; Woodlock T; Collister D
    Can J Kidney Health Dis; 2023; 10():20543581231209012. PubMed ID: 37920777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic Kidney Disease Back in Focus: Management Field Guide for Health Care Professionals in the 21st Century.
    Alicic R; Nicholas SB
    Mayo Clin Proc; 2022 Oct; 97(10):1904-1919. PubMed ID: 36202498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision medicine approaches for diabetic kidney disease: opportunities and challenges.
    Tye SC; Denig P; Heerspink HJL
    Nephrol Dial Transplant; 2021 Jun; 36(Suppl 2):3-9. PubMed ID: 34153985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Systems Nephrology Approach to Diabetic Kidney Disease Research and Practice.
    Martin WP; Docherty NG
    Nephron; 2024; 148(3):127-136. PubMed ID: 37696257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.
    Helou N; Dwyer A; Shaha M; Zanchi A
    JBI Database System Rev Implement Rep; 2016 Jul; 14(7):169-207. PubMed ID: 27532796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease.
    Alicic RZ; Johnson EJ; Tuttle KR
    Adv Chronic Kidney Dis; 2018 Mar; 25(2):181-191. PubMed ID: 29580582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of histopathological and clinical spectrum of diabetic kidney disease based on an unsupervised hierarchical clustering analysis of elderly autopsy specimens.
    Sugimoto H; Yumura W; Yamaguchi Y; Yamanaka N; Hashimoto S; Arai M; Matsuno S; Shimizu A; Arai T; Itabashi M; Takei T
    Nephrology (Carlton); 2022 Aug; 27(8):701-711. PubMed ID: 35436030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study.
    Zhang J; Fuhrer T; Ye H; Kwan B; Montemayor D; Tumova J; Darshi M; Afshinnia F; Scialla JJ; Anderson A; Porter AC; Taliercio JJ; Rincon-Choles H; Rao P; Xie D; Feldman H; Sauer U; Sharma K; Natarajan L
    Am J Nephrol; 2022; 53(2-3):215-225. PubMed ID: 35196658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of risk models for major adverse chronic renal outcomes among patients with type 2 diabetes mellitus using insurance claims: a retrospective observational study.
    Wysham CH; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Duh MS; Young JB
    Curr Med Res Opin; 2020 Feb; 36(2):219-227. PubMed ID: 31625766
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeting inflammation for the treatment of Diabetic Kidney Disease: a five-compartment mechanistic model.
    Hofherr A; Williams J; Gan LM; Söderberg M; Hansen PBL; Woollard KJ
    BMC Nephrol; 2022 Jun; 23(1):208. PubMed ID: 35698028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of patients with type 2 diabetes attending a multidisciplinary diabetes kidney disease clinic.
    Low S; Lim SC; Wang J; Yeoh LY; Liu YL; Lim EK; Shao YL; Chui W; Fun S; Chua CL; Subramaniam T; Sum CF
    J Diabetes; 2018 Jul; 10(7):572-580. PubMed ID: 29154443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.